Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRIDES PHARMA SCIENCE LIMITED Board/Management Information 2019

Jul 31, 2019

62616_rns_2019-07-31_f865e171-1a0e-4d88-ad01-88d2248d7608.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

July 31, 2019

The BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex, Dalal Street, Mumbai – 400 001 Bandra (E), Mumbai - 400 051. Scrip Code: 532531 Scrip Code: STAR

Dear Sir,

Sub: Update

It is with sincere regret that the Board of Directors (Board) of Strides Pharma Science Limited (Strides or Company) inform that Ms. Sangita Reddy (Sangita) will step-down as an Independent Director of the Company.

Inspite of Sangita’s pre-occupation as a successful entrepreneur, she contributed significantly to the Company’s growth, particularly when the Company was resetting its Strategy. She was always available to the Board for any guidance. The Board acknowledges Sangita’s valuable contributions to the Company.

In view of her vast corporate experience, the Board has requested Sangita to consider the role of a strategic board advisor so that the Board continues to benefit from her expertise.

Sangita was appointed as Independent Director of the Company for a period of five years at the 23[rd] Annual General Meeting held on September 9, 2014.

ABOUT STRIDES

Strides, listed on the BSE Limited (532531) and National Stock Exchange of India Limited (STAR), is a global pharmaceutical company headquartered in Bangalore, India. The Company mainly operates in the regulated markets and has an “in Africa for Africa” strategy along with an institutional business to service donor-funded markets. The Company’s global manufacturing sites are located in India- Bangalore (two sites), Pondicherry, and Chennai, Singapore, Italy- Milan, and Kenya- Nairobi. The Company focusses on “difficult to manufacture” products that are sold in over 100 countries. Additional information is available at the Company’s website at www.strides.com

Strides Pharma Science Limited

(Formerly Strides Shasun Limited) CIN: L24230MH1990PLC057062 Corp Off : Strides House, Bilekahalli, Bannerghatta Road, Bangalore - 560 076, India Tel: +91 80 6784 0000 Fax: +91 80 6784 0700 Regd Off : 201, Devavrata, Sector 17, Vashi, Navi Mumbai – 400 703, India Tel: +91 22 2789 2924 / 3199 Fax: +91 22 2789 2942 [email protected]; www.strides.com

For further information, please contact:

StridesBadree KomandurExecutive Director – Finance & Group CFO+91 80 6784 0747Investor Relations:Kannan. N:+91 98450 54745Vikesh Kumar:+91 80 6784 0827Sandeep Baid:+91 80 6784 0791Email: [email protected] PR ConsultancyFortuna PRK Srinivas Reddy: +91 90005 27213[email protected]K Priya: +91 95354 25418[email protected]

Thanks & Regards,

For Strides Pharma Science Limited

==> picture [122 x 50] intentionally omitted <==

Manjula Ramamurthy Company Secretary

==> picture [91 x 88] intentionally omitted <==

Strides Pharma Science Limited

(Formerly Strides Shasun Limited) CIN: L24230MH1990PLC057062 Corp Off : Strides House, Bilekahalli, Bannerghatta Road, Bangalore - 560 076, India Tel: +91 80 6784 0000 Fax: +91 80 6784 0700 Regd Off : 201, Devavrata, Sector 17, Vashi, Navi Mumbai – 400 703, India Tel: +91 22 2789 2924 / 3199 Fax: +91 22 2789 2942 [email protected]; www.strides.com